Page last updated: 2024-11-02

piracetam and Diabetes Mellitus, Type 1

piracetam has been researched along with Diabetes Mellitus, Type 1 in 3 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reda, HM1
Zaitone, SA1
Moustafa, YM1
Baratsevich, ER1
Posokhina, OV1
Zesiewicz, TA1
Pathak, A1
Sullivan, KL1
Shamayev, M1
Hauser, RA1

Other Studies

3 other studies available for piracetam and Diabetes Mellitus, Type 1

ArticleYear
Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: Influence on spinal microglia and astrocytes.
    European journal of pharmacology, 2016, Jan-15, Volume: 771

    Topics: Amines; Animals; Astrocytes; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetes

2016
[Approaches to the therapy of neurological presentations in diabetes mellitus].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:4

    Topics: Adult; Aged; Antioxidants; Cognition Disorders; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2

2010
Treatment of chorea with levetiracetam.
    European journal of clinical pharmacology, 2006, Volume: 62, Issue:1

    Topics: Acute Disease; Adult; Anticonvulsants; Chorea; Diabetes Mellitus, Type 1; Female; Humans; Levetirace

2006